We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

60 hedge funds and large institutions have $15.7M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 17

0% more funds holding

Funds holding: 60 → 60 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

65% less capital invested

Capital invested by funds: $44.4M → $15.7M (-$28.7M)

Holders
60
Holders Change
–
Holders Change %
0%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
18
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$197K
2
BCM
Bridgeway Capital Management
Texas
+$111K
3
YIH
Y-Intercept (HK)
Hong Kong
+$77.4K
4
CWM
Congress Wealth Management
Massachusetts
+$69.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$64.5K

Top Sellers

Rank Fund Capital Flow
1
Baird Financial Group
Baird Financial Group
Wisconsin
-$452K
2
BlackRock
BlackRock
New York
-$264K
3
ROTUOC
Regents of the University of California
California
-$234K
4
Swiss National Bank
Swiss National Bank
Switzerland
-$216K
5
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$192K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$3.97M – – –
CGC
2
Continental Grain Company
New York
$2.8M – – –
BlackRock
3
BlackRock
New York
$2.14M -$264K -344,108 -6%
TCM
4
Tao Capital Management
California
$1.16M – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$765K -$147K -191,767 -10%
BOTOTLSJU
6
Board of Trustees of The Leland Stanford Junior University
California
$729K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$696K +$30K +39,113 +2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$634K +$64.5K +83,976 +6%
State Street
9
State Street
Massachusetts
$434K -$151K -196,239 -16%
Baird Financial Group
10
Baird Financial Group
Wisconsin
$417K -$452K -588,390 -38%
Northern Trust
11
Northern Trust
Illinois
$312K -$35.1K -45,721 -6%
BNP Paribas Asset Management
12
BNP Paribas Asset Management
France
$305K -$192K -250,546 -26%
Charles Schwab
13
Charles Schwab
California
$260K -$5.06K -6,588 -1%
Renaissance Technologies
14
Renaissance Technologies
New York
$111K +$197K +256,300 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$107K +$5.53K +7,201 +3%
Millennium Management
16
Millennium Management
New York
$100K +$63.3K +82,461 +55%
State of Tennessee, Department of Treasury
17
State of Tennessee, Department of Treasury
Tennessee
$75.8K – – –
BCM
18
Bridgeway Capital Management
Texas
$62.7K +$111K +145,000 New
N
19
Nuveen
North Carolina
$45K – – –
YIH
20
Y-Intercept (HK)
Hong Kong
$43.6K +$77.4K +100,820 New
CWM
21
Congress Wealth Management
Massachusetts
$38.9K +$69.1K +90,000 New
Allspring Global Investments
22
Allspring Global Investments
North Carolina
$34.8K +$43.6K +56,810 +239%
Morgan Stanley
23
Morgan Stanley
New York
$33.9K +$12.5K +16,228 +26%
JP Morgan Chase
24
JP Morgan Chase
New York
$30K +$14K +18,180 +36%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$29K +$600 +782 +1%
1
2 3

GRNA Hedge Fund Activity: Q1 2023 in Review

60 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q1 2023, worth a combined $15.7M — down 65% from $44.4M a quarter earlier.

Fund positioning in GRNA was balanced in Q1 2023: 9 funds opened new positions, 9 closed out, 18 added to existing stakes and 17 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $197K. The largest seller was Baird Financial Group, cutting an estimated $452K.

  • 60 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $15.7M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q1 2023, down 65% quarter-over-quarter.
  • 9 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q1 2023 and 9 closed out, a net change of 0 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q1 2023 was Renaissance Technologies, an estimated $197K added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q1 2023 was Baird Financial Group, an estimated $452K sold.

Based on aggregated 13F filings for Q1 2023.